FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk
Medical Oncology · 10.11.2026 · 43 (12)
DOI: 10.1007/s12032-026-03495-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 10.11.2026. Verfasst von Fuzhou Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Pr…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, MicroRNAs, Cuproptosis, Kidney Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the National Natural Science Foundation Cultivation Project of Guizhou Medical University, the Science and Technology Foundation of Guizhou Province.
Abstract (Originalsprache)
Inactive cuproptosis has been linked to the progression of clear cell renal cell carcinoma (ccRCC); however, the underlying molecular mechanisms remain unclear. In this study, a cuproptosis-related scoring system, termed the cuproptosis suppression score (CSS) was developed based on multiple cuproptosis-related genes. Single-cell RNA-sequencing data were employed to examine the correlations between the CSS and the immune landscape and metabolic reprogramming. Luciferase reporter assays and in vitro functional experiments were conducted to analyze the potential competitive endogenous RNA mechanism regulating FDX1 expression and to evaluate the functional effects of FDX1 in ccRCC development. We observed that the CSS was inversely correlated with the expression levels of cuproptosis-promoting genes. High-CSS tumor cells exhibited enrichment of the epithelial-mesenchymal transition, angiogenesis, and RTK/RAS pathways. Cuproptosis appeared to influence tumor progression by modulating metabolic reprogramming and remodeling the immune microenvironment, with cuproptosis-related intercellular and cytokine signaling potentially alleviating T cell exhaustion. Notably, the CSS accurately predicted immunotherapy responses. Furthermore, FDX1, a key cuproptosis regulator, was inversely linked to the CSS, and its upregulation suppressed ccRCC cell proliferation and migration. The lncRNA FGD5-AS1 upregulated FDX1 by sponging miR-106b-5p. Altogether, this study provides mechanistic insights into how cuproptosis may limit ccRCC progression, potentially through metabolic reprogramming and tumor immune escape. Cuproptosis-based anticancer strategies hold significant promise for integration into precision medicine in ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, Guizhou Medical University, Guiyang, China.
- Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China.
- MOE key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou, China.
- Department of Anesthesiology, the Affiliated Hospital of Guizhou Medical University, Guizhou Medical University, Guiyang, Guizhou, China. yimin-ren@qq.com.
- Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China. ouyangyan@gmc.edu.cn.
- Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang, China. zhangshch08@lzu.edu.cn.
ORCID-Profile: Fuzhou Tang
Förderung
- the National Natural Science Foundation of China
- the National Natural Science Foundation Cultivation Project of Guizhou Medical University
- the Science and Technology Foundation of Guizhou Province
- the 7th Batch of Guizhou Province Thousand-Layer Talent Plan
Zitieren
APA
Tang, F., Wang, W., Chang, Y., Gu, Y., Wei, X., Ren, Y., Ouyang, Y., & Zhang, S. (2026). FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03495-0
Vancouver
Tang F, Wang W, Chang Y, Gu Y, Wei X, Ren Y, et al. FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03495-0
BibTeX
@article{Tang2026,
author = {Tang, Fuzhou and Wang, Weirong and Chang, Yue and Gu, Yan and Wei, Xianpeng and Ren, Yimin and Ouyang, Yan and Zhang, Shichao},
title = {FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {12},
doi = {10.1007/s12032-026-03495-0}
}
EUVIMED